JP2024524696A5 - - Google Patents
Info
- Publication number
- JP2024524696A5 JP2024524696A5 JP2024501992A JP2024501992A JP2024524696A5 JP 2024524696 A5 JP2024524696 A5 JP 2024524696A5 JP 2024501992 A JP2024501992 A JP 2024501992A JP 2024501992 A JP2024501992 A JP 2024501992A JP 2024524696 A5 JP2024524696 A5 JP 2024524696A5
- Authority
- JP
- Japan
- Prior art keywords
- transcription activator
- nucleic acid
- transcription
- expression construct
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163221611P | 2021-07-14 | 2021-07-14 | |
| US63/221,611 | 2021-07-14 | ||
| PCT/CA2022/051100 WO2023000081A1 (en) | 2021-07-14 | 2022-07-14 | Trans-activators and methods and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024524696A JP2024524696A (ja) | 2024-07-05 |
| JP2024524696A5 true JP2024524696A5 (https=) | 2025-07-22 |
Family
ID=84980468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024501992A Pending JP2024524696A (ja) | 2021-07-14 | 2022-07-14 | トランス活性化因子ならびにその方法及び使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240309360A1 (https=) |
| EP (1) | EP4370685A4 (https=) |
| JP (1) | JP2024524696A (https=) |
| KR (1) | KR20240032943A (https=) |
| CN (1) | CN117795084A (https=) |
| AU (1) | AU2022313698A1 (https=) |
| CA (1) | CA3224438A1 (https=) |
| WO (1) | WO2023000081A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024213573A1 (en) * | 2023-04-13 | 2024-10-17 | Vector Biopharma Ag | Inducible expression system |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030194704A1 (en) * | 2002-04-03 | 2003-10-16 | Penn Sharron Gaynor | Human genome-derived single exon nucleic acid probes useful for gene expression analysis two |
| WO2003089622A2 (en) * | 2002-04-22 | 2003-10-30 | University Of Michigan | Novel genes, compositions, and methods for modulating the unfolded protein response |
| US12415844B2 (en) * | 2017-12-20 | 2025-09-16 | Poseida Therapeutics, Inc. | BCMA specific VCAR compositions and methods for use |
| WO2023173012A2 (en) * | 2022-03-09 | 2023-09-14 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions for activating and silencing gene expression |
-
2022
- 2022-07-14 JP JP2024501992A patent/JP2024524696A/ja active Pending
- 2022-07-14 KR KR1020247004270A patent/KR20240032943A/ko active Pending
- 2022-07-14 CA CA3224438A patent/CA3224438A1/en active Pending
- 2022-07-14 WO PCT/CA2022/051100 patent/WO2023000081A1/en not_active Ceased
- 2022-07-14 US US18/575,279 patent/US20240309360A1/en active Pending
- 2022-07-14 CN CN202280054820.1A patent/CN117795084A/zh active Pending
- 2022-07-14 EP EP22844764.5A patent/EP4370685A4/en active Pending
- 2022-07-14 AU AU2022313698A patent/AU2022313698A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gu et al. | Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. | |
| Yie et al. | The role of HMG I (Y) in the assembly and function of the IFN‐β enhanceosome | |
| Bos et al. | v-jun encodes a nuclear protein with enhancer binding properties of AP-1 | |
| Giffin et al. | Sequence-specific DNA binding by Ku autoantigen and its effects on transcription | |
| Kataoka et al. | Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun | |
| Cordle et al. | Pancreatic β-cell-type-specific transcription of the insulin gene is mediated by basic helix-loop-helix DNA-binding proteins | |
| Tsurutani et al. | Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells | |
| Bies et al. | An intact cysteine-rich domain is required for dystrophin function. | |
| Hsu et al. | Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells. | |
| Ruhl et al. | Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation. | |
| JP2022002530A (ja) | ウイルスベクター効率を改善するための組成物及び方法 | |
| Pessler et al. | Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts | |
| Satyamoorthy et al. | The intracisternal A-particle upstream element interacts with transcription factor YY1 to activate transcription: pleiotropic effects of YY1 on distinct DNA promoter elements | |
| JPH04505012A (ja) | ホルモン応答要素組成物およびアッセイ | |
| Lacy et al. | Biochemical studies on adenovirus multiplication, VII. Homology between DNA's of tumorigenic and nontumorigenic human adenoviruses | |
| JP2009100754A (ja) | プロテアーゼ検出系 | |
| CN107501405B (zh) | 一种细胞自噬抑制多肽 | |
| HARPER et al. | Expression of neuropilin-1 by human glomerular epithelial cells in vitro and in vivo | |
| JP2023537158A (ja) | Ｋｒａｂ融合抑制因子並びに遺伝子発現を抑制する方法及び組成物 | |
| JPH111498A (ja) | Ｍｙｃ結合性亜鉛フィンガータンパク質、その製造方法及びその使用 | |
| JP2024524696A5 (https=) | ||
| Ong et al. | Activation of multifarious transcription of an adhesion protein ap65-1 gene by a novel Myb2 protein in the protozoan parasite Trichomonas vaginalis | |
| Skerjanc et al. | The E box is essential for activity of the cardiac actin promoter in skeletal but not in cardiac muscle | |
| Yamamoto et al. | Binding Sequence of STAT4: STAT4 Complex Recognizes the IFN-γ Activation Site (GAS)-like Sequence (T/A) TTCC (C/G) GGAA (T/A) | |
| Kikuchi et al. | Structure of the murine secretory leukoprotease inhibitor (Slpi) gene and chromosomal localization of the human and murine SLPI genes |